Trade Grifols, S.A. - GRLS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.017954% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004268% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Spain | ||||||||
| Commission on trade | 0% |
| Prev. Close | 8.03 |
| Open | 8.03 |
| 1-Year Change | -3.83% |
| Day's Range | 7.99 - 8.11 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 17, 2025 | 8.03 | -0.12 | -1.47% | 8.15 | 8.19 | 7.98 |
| Apr 16, 2025 | 8.16 | 0.04 | 0.49% | 8.12 | 8.16 | 7.94 |
| Apr 15, 2025 | 8.25 | 0.10 | 1.23% | 8.15 | 8.26 | 8.09 |
| Apr 14, 2025 | 8.10 | 0.06 | 0.75% | 8.04 | 8.13 | 7.96 |
| Apr 11, 2025 | 7.79 | -0.17 | -2.14% | 7.96 | 7.96 | 7.62 |
| Apr 10, 2025 | 7.86 | -0.85 | -9.76% | 8.71 | 8.77 | 7.80 |
| Apr 9, 2025 | 7.38 | -0.31 | -4.03% | 7.69 | 7.76 | 7.31 |
| Apr 8, 2025 | 7.98 | -0.14 | -1.72% | 8.12 | 8.15 | 7.82 |
| Apr 7, 2025 | 7.80 | 0.18 | 2.36% | 7.62 | 8.24 | 7.29 |
| Apr 4, 2025 | 8.10 | -0.20 | -2.41% | 8.30 | 8.35 | 7.91 |
| Apr 3, 2025 | 8.35 | -0.13 | -1.53% | 8.48 | 8.67 | 8.30 |
| Apr 2, 2025 | 8.36 | -0.26 | -3.02% | 8.62 | 9.33 | 8.29 |
| Apr 1, 2025 | 8.07 | -0.16 | -1.94% | 8.23 | 8.36 | 8.03 |
| Mar 31, 2025 | 8.18 | -0.33 | -3.88% | 8.51 | 8.51 | 8.11 |
| Mar 28, 2025 | 8.54 | -0.15 | -1.73% | 8.69 | 8.75 | 8.53 |
| Mar 27, 2025 | 8.62 | -0.28 | -3.15% | 8.90 | 8.90 | 8.60 |
| Mar 26, 2025 | 8.89 | -0.16 | -1.77% | 9.05 | 9.05 | 8.82 |
| Mar 25, 2025 | 9.10 | -0.11 | -1.19% | 9.21 | 9.23 | 9.06 |
| Mar 24, 2025 | 9.15 | -0.10 | -1.08% | 9.25 | 9.25 | 9.11 |
| Mar 21, 2025 | 9.19 | -0.11 | -1.18% | 9.30 | 9.35 | 9.14 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Grifols Company profile
About Grifols SA
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Grifols SA revenues decreased 8% to EUR4.93B. Net income before extraordinary items decreased 72% to EUR182.8M. Revenues reflect Bioscience segment decrease of 10% to EUR3.81B, United States/Canada segment decrease of 12% to EUR3.15B, Rest of the World segment decrease of 4% to EUR872.1M. Net income also reflects Selling/General/Admin. Expense - Balanci increase of 11% to EUR567.3M (expense).
Equity composition
12/11, 10% Stock dividend. 12/2011, Scrip Issue, 1 new share for every 10 shares held @ EUR0.1 (Factor: 1.1), 12/2012, Scrip Issue, 1 new B shares for every 20 B shares held (Factor: 1.05). 1/2016, 2-for-1 stock split (Factor: 2).
| Industry: | Biopharmaceuticals |
C/ Jesús y María, 6
BARCELONA
BARCELONA 08022
ES
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com